Description
Each vial contains 25mg of highly pure Cartalax in lyophilized form.
Cartalax is a peptide-based compound designed to support joint health and cartilage function. It is studied for its potential to promote cartilage repair, reduce inflammation, and improve joint mobility, making it of interest for conditions involving joint injury or degeneration.
It is typically administered under professional supervision through intramuscular or intra-articular injection.
Reconstitution
Add 2.5mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of Cartalax.
Storage
This product must be refrigerated after reconstitution.
